p+ phenotype, while one patient (BA) was CD8+4+CD16+ TCRa//3+. Freshly isolated granular lymphocytes (GL) from these cases displayed cytolytic activity in an anti-CD3 MoAbtriggered redirected killing assay against the Fcy-receptor+ (Fcy-R+) P815 target cell line. Lysis of P815 target cells, triggered by an anti-CD3 or by anti-CD16 MoAb, could be inhibited by the addition of anti-p58 MoAb in three fresh or interleukin (IL)-2-cultured GL tested (GI, MA, and PU). Triggering of cytotoxicity against the HLA-DR+ Fcy-R+ Daudi cell line induced by appropriate superantigens could also be YMPHOPROLIFERATIVE disease of granular lymphocytes (LDGL) is a rare disorder characterized by a chronic proliferation of granular lymphocytes (GL) that may belong either to the CD3+ T-cell lineage or to the CD3-natural killer (NK) cell lineage."4 CD3+ LDGLs are usually characterized by the clonal proliferation of T-cell receptor (TCR) (YIP+ lymphocytes and represent the most common form of this disease, accounting for approximately 85% of LDGL cases. These CD3+ LDGLs frequently express the CD8 and the NK-related CD16 surface antigen and display, on in vitro interleukin (1L)-2 activation, cytolytic activity against NK-sensitive targets.
Although the molecular mechanisms involved in NK cell recognition are still poorly defined, several functional surface receptor molecules have been identified on the NK cell surface by the use of monoclonal antibodies ( M o A~s ) .~,~ Some of these molecules, including CD2' and CD16,' appear to act as "triggering" surface receptors that activate NK cell functions. Other receptors, such as those belonging to the "p58" molecular family, inhibit NK cell activation.' The EB6 and GL-183 anti-p58 MoAbs, define partially overlapping subsets of NK cells, which specifically recognize different groups of HLA-C The expression of these alleles protects target cells from NK cell-mediated lysis. The interaction of p58 molecules with HLA-C may induce a "negative" signal that inhibits NK cell triggeri~~g.""~ In fact, when this interaction is blocked by anti-p58 MoAbs or by appropriate anti-HLA MoAbs, cytolysis of target cells expressing protective HLA class I alleles could be "restored." Interestingly, functional p58 molecules have also been recently detected on a minor subset of T lymphocytes (0.5% to 10%) in healthy donor^.'^*'^ Taking advantage of a large series of CD3+ LDGL patients and expanded GL with rare phenotype, in this paper, we studied the p58 receptor family complex, both on phenotypical and functional inhibited by anti-p58 MoAb in patients PU and GI with LDGL. These data indicate that activation through the CD16, CD3, and TCR molecules can be modulated by p58 receptors in these LDGLs. On the contrary, IL-2-expanded cells of patient BA were induced t o lyse P815 target cells by anti-p58 MoAb.
In addition, anti-p58 MoAb enhanced anti-CD16 MoAb triggered lysis and did not inhibit activation via CD3. These data indicate that, in this particular patient with LDGL, p58 displays a stimulatory effect on cell triggering, rather than the typical inhibitory effect previously observed in p58+ T-cell clones derived from healthy donors. The antbp58 MoAb did not induce CB++ mobilization in p58+ LDGLs and in a p58+CD3+ normal T-cell clone equipped with inhibitory p58 molecules, while CB++ mobilization could be observed in cultured GL from patient BA, which could be activated by antip58 MoAb. These findings suggest that stimulatory and inhibitory p58 molecules are equipped with different signal transducing properties, thus contributing t o a better knowledge of the normal counterpart.
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grounds, with the ultimate goal of better understanding the properties of the normal p58' T-cell counterpart. In particular, we analyzed the expression of p58 molecules on CD3+16+ GL, and we found that a minority of LDGL patients express p58 receptors. On three of such CD3+16+p58+ LDGL cases, p58 molecules display inhibitory functions on cell triggering through CD3, TCR, or CD16 activation pathways. In one case, however, they functioned as triggering surface receptors, mediating activation of cytolytic activity and Ca++ mobilization.
MATERIALS AND METHODS
Patients. Four patients with CD3+ LDGL were selected among a series of 44 cases for the expression of p58 molecules. All patients suffered from persistent (>6 months) lymphocytosis characterized by >2,000 granular lymphocytes/m', ranging from 2,100 to 12,300/mm' (normals, 223 5 99/mm3). No history of either transfusion of blood products or intravenous Ig administration, no history of drug abuse or at risk sexual behavior could be documented in any of these patients. All patientr showed an asymptomatic clinical course. At time of the study, no patient was receiving specific therapy. All cases, except one, showed a monoclonal rearrangement of TCRB genes, as demonstrated by Southern blot analysis (data not shown). In one case (patient PU), using polymerase chain reaction (PCR) analysis with Vp specific primers, proliferating granular lymphocytes expressed only two TCR Vg gene products (TCR Vp7 and VP20). Patients PU, BA, and MA were found to he positive for antibodies against hepatitis C virus (HCV), as detected by the use of an enzyme immunoassay (EIA; Abbott, Rome, Italy) and by a recombinant immunoblotting assay (RIBA; Chiron Corp, Emeriville, CA), which showed the presence of antibodies against four HCV peptides. Patient GI had a persistent lymphocytosis, consisting of CL, 6 months after a classical infectious mononucleosis. Cytolytic assay. Freshly isolated or IL-2-cultured GL were used as effector cells at effector:target cell ratios ranging from 1: 1 to 20: l. The "NK-sensitive" human leukemia K.562, the Burkitt-lymphoma Raji, and Daudi cell lines and the murine mastocytoma cell line P815 were used as target cells. P815 was used as target cell for MoAb redirected killing assay," while the HLA class 11' Daudi cell line was used for superantigen-mediated cell triggering. Briefly, 5
x 10' "Cr-labelled target cells were added to effector cells in the presence of 20 pL of anti-CDl6, anti-CD3, CH-L hybridoma supernatant, either alone or in different combinations. Anti-CD2 and anti-CD7 MoAbs were used as negative controls. The final culture volume was 200 pL for each well of 96-well microtiter plates. After 4 hours of culture, 100 pL were collected from each well and counted in a y-counter for the determination of 5'Cr-release. Percentage of lysis was determined as previously described." For superantigendependent cell lysis on Daudi cells, a final concentration of 1 ng/ mL of staphylococcal enterotoxin (SE) C-l, SEC-2, SEC-3, SEA, SEE, or toxic shock syndrome toxin-1 (TSST-I ; Toxin Technology, Sarasota, FL) were added to each well at the onset of the assay.
Ca+' mobilization assay. For the determination of free Ca" cytoplasmic concentration p58' cultured GL cells (2.5 X IO6) were 
RESULTS

Phenotypic characteristics
of four CD3'p58+ LDGL.
Among a series of patients with CD3' LDGL taken into account (44 cases), four patients expressed the NK-related receptor molecule p58, detected by the GL183 and CH-L anti-p58 MoAbs. It is noteworthy that a common clinical feature shared by the four patients with CD3+p58' LDGLs was represented by a previous or concomitant viral infection by HCV (in three patients) or by EBV (in one patient). Most PBL from these four patients reacted with the anti-p58 MoAbs CH-L (Table 1) and GL183 (not shown), while GL of patients PU and MA were weakly stained by the anti-p58 MoAb EB6, which identifies a member of the p58 molecular family different from that recognized by GL-183 and CH-L MoAbs. All GL expressed TCR do, CD3, CD16, and CD8 surface molecules, while two of four cases were also CD56+. Cells from one LDGL (BA) coexpressed CD4 (Fig l) , while the others were CD4 negative. Coexpression of p58 and CD3 or CD8 on the same cells was confirmed by two-color immunofluorescence analysis (Fig 1) . These phenotypic characteristics were found to be remarkably stable in two of these LDGL populations (PU and BA), which could be grown in culture for 2 to 4 weeks in IL-2 containing medium, while attempts to culture MA and GI GL for more than 2 weeks led to the overgrowth of p58-negative T lymphocytes.
Cytolytic activity offieshly isolated or IL-2 cultured p58'
LDGLs is regulated by p58 molecules. All freshly isolated p58' LDGLs displayed cytolytic activity in a redirected killing assay against the Fcy-R+ P815 target cells using anti-CD3 MoAb (Fig 2) . It is noteworthy that, under the same experimental conditions, the CH-L anti-p58 MoAb failed to trigger cytolysis by resting lymphocytes of the four patients (Fig 2) .
It is known that binding of anti-p58 MoAb to Fcy-R' target cells induces cross-linking of p58 molecules of the effector cells, thus mimicking the recognition of the "natural" cellular ligand of p58 (ie, major histocompatibility complex [MHC] class I). This results in a negative signal that blocks the triggering of the cytolytic machinery mediated by other MoAbs directed to stimulatory molecule^.'^^'^ As shown in Fig 2, the addition of anti-p58 MoAb to the anti-CD3 MoAb redirected killing assay sharply inhibited cytolytic activity in three of four LDGL patients (GI, MA, and PU), while irrelevant MoAbs were ineffective. A similar inhibitory effect of anti-p58 MoAb was also observed when anti-CD16 MoAb was used as triggering stimulus (data not shown). Different from these LDGL patients, in the fourth LDGL patient (BA), the anti-p58 MoAb had no inhibitory effect on the anti-CD3 MoAb-mediated cell triggering.
An inhibitory effect of anti-p58 MoAb on anti-CD3 or anti-CD16 MoAb mediated P815 lysis could be observed on patient PU, also following a 4-week culture in IL-2 (Fig 3A  and B) . Consistent data were obtained with patients MA and GI after short-term culture in IL-2 (data not shown). By contrast, anti-CD3 MoAb-mediated lysis by IL-2-expanded cells of patient BA was not affected by anti-p58 MoAb ( Fig  3C) and anti-CD16 MoAb-mediated lysis was enhanced, rather than inhibited, by anti-p58 MoAb (Fig 3D) . More importantly, anti-p58 MoAb alone induced P815 target cell lysis, thus suggesting that p58 molecule triggering produces a stimulatory effect on IL-2-cultured GL of this particular LDGL patient.
To further demonstrate the regulatory role of p58 molecules in T-cell activation mediated by TCR molecules, we used a superantigen-dependent cytotoxic assay against the MHC class II+, Fcy-R+ Daudi cell line. In fact, the GL from patient PU were able to lyse Daudi, as well as other targets expressing class-I1 molecules, such as Raji (not shown), in the presence of SEC-l, -2 or -3 superantigens, whereas SEA, SEE, and TSST-l were unable to trigger cytotoxicity of patient PU GL. In this assay, the superantigen triggers cytotoxicity by binding to a nonpolymorphic portion of the MHC class I1 molecule on the target cells and to the Vp region of the TCR of the effector cells." This selective effect of given superantigens was not surprising because this LDGL patient expressed VD 7 and VD 20; the latter is known to interact anti-CD3 MoAb resulted in a significant increase of [Ca"l, in these CL or in the T-cell clone (Fig S ) .
Different results were obtained with CL of patient BA (Fig  S , lower panels) , which were activated by anti-p58 MoAb in the redirected killing cytotoxicity assay. These cells showed a significant increase of [Ca"], in response to anti-p58 MoAb cross-linking induced by the addition of RAMIG. Consistent findings were observed in three unrelated experiments, thus suggesting that [Ca"' 1, is involved in signal transduction via stimulatory p58 molecules.
DISCUSSION
In this study, we have analyzed four CD3' LDGL patients characterized by the expression on expanding cells of the NK-related receptor pS8, specific for HLA-C alleles. Remarkably, the p58 molecules expressed in the different CL taken into account could exert either inhibitory or stimulatory effects on triggering of cytolytic functions. In addition, only stimulatory receptors mediated Ca++ mobilization.
Previous studies demonstrated that: ( l ) pS8' T-cell clones, derived from normal individuals, were in most instances CD8+4-TCRa/@+; (2) these pS8' T-cell clones expressed "NK-like" activity; and (3) p58 molecules may negatively with SEC superantigens, but not with SEA, SEE, or TSST-1. As shown in Fig 4, the cytolysis of Daudi cells mediated by patient PU effector cells, in the presence of SEC-l, SEC-3, or SEC-2 (not shown) was sharply inhibited by the antip58 MoAb CH-L, while control MoAbs had no effect.
Similarly, anti-p58 MoAb inhibited SEE superantigen-induced cytotoxicity mediated by the V 0 16+ GL from patient MA (Fig 4C) . The GL from patients BA and GI were not significantly triggered by any of the superantigens of the available panel.
Effect of anti-p58 MoAb on Ca++ mobilization. We investigated whether signalling via p58 involved changes in the free intracytoplasmic Ca++ levels ([Ca"],) in cultured GL of LDGL patients and, for comparison in the p58+CD3+ T-cell clone OB12.1, derived from a healthy donor, in which p58 were previously shown to inhibit CD3iTCR-mediated cell triggering.I4 As shown in the representative experiment reported in Fig 5, CH-L MoAb, alone or after the addition of a rabbit antimouse antiserum (RAMIG) as cross-linking agent, failed to induce a significant [Ca++Ii mobilization in GL of patients PU and MA, in which p58 behaved as an inhibitory surface receptor molecule in the cytolytic assays reported above. Consistent with this finding, no significant changes in [Ca"], were detected in the OB12.1 T-cell clone. At difference, the addition of phytohemagglutinin (PHA) or regulate T-cell activation triggered via the CD3/TCR complex.14 Three p58' LDGL patients displayed phenotypic and functional characteristics similar to the most common prototype of these normal p58+ T cells, from which these LDGL are likely to arise. In addition, in these GL, the cytolytic activity triggered by anti-CD3 MoAb or by superantigens could be inhibited by anti-p58 MoAb on Fcy-R+ cell lines. These findings provide evidence that, in these GL, stimulatory signals delivered via CD3 or TCR molecules can be negatively modulated by the simultaneous triggering of p58 receptors by cell-bound ligands. A similar negative regulatory function on superantigen-dependent T-cell cytotoxicity has been recently described for another NK-related receptor for MHC molecules, termed NKB 1, which is also expressed on a subset of normal T lymphocytes." The finding that GL from LDGL patients acquired cytolytic activity against the HLA-negative K562,"4 but did not lyse IFNy-treated K562 that express HLA class I (data not shown), suggests that the "NK-like" activity of cases under study could be inhibited by expression of HLA molecules on target cells, in a similar fashion as in NK cells.15 This hypothesis was further substantiated by the observation that HLA class I negative target cells transfected with the Cw3 allele became resistant to cytolysis by LDGL (data not shown). Therefore, it is conceivable that p58 molecules may act as receptors for HLA-C also in these CD3+ LDGLs, as recently demonstrated for p58' T-cell clones derived from normal individuals.'s The constitutive expression of cytolytic properties, which could be triggered via the CD3/TCR complex, strongly suggests that GL in these patients may represent in vivo primed cytotoxic T lymphocytes (CTLs)? The finding that in all four patients a viral infection (by HCV or EBV) was detected, may be consistent with the previously hypothesized role of viral infections in the pathogenesis of some LDGLS.I~.*I However, it should be noted that this event represents a quite uncommon feature for CD3+ T cell type LDGL, while viral infections have been more frequently associated with CD3-NK-type LDGL.'d,2' In this context, a previous report indiFor personal use only. on April 15, 2017. by guest www.bloodjournal.org From cated that CD3+p58+ lymphocytes were increased in patients with human immunodeficiency virus (HIV) infection," but the occurence of changes in this T-cell subset during HCV or EBV infection, has not yet been established. Concerning the possible physiological role of the p58-mediated inhibition in CTL function, this may be related to the prevention of inappropriate lysis of autologous cells expressing self MHC molecules. One may speculate that downregulation of MHC molecule expression or its occupancy by viral-encoded peptides may alter recognition of self MHC alleles by p58 molecules and allow target cell lysis.
Another relevant finding is that in these LDGLs the triggering mediated via CD16 could be inhibited by p58 molecules, in a similar fashion as in CD3-16+ NK clones derived from normal individuals.' However, a different functional behavior of p58 molecules was described in a previous report in CD3-NK LDGLs, in which the cytolytic activity against Fcy-R' targets could be activated, instead of inhibited by anti-p58 MoAbsZ3 A similar stimulatory functional role of p58 molecules was found in the fourth p58' LDGL patient reported in the present study. In addition, in this particular LDGL case, the signalling via p58 receptor upregulated the cytotoxicity induced by anti-CD16 MoAb, while anti-CD3-mediated cytolysis was not affected.
Intracellular mobilization of free Ca++ is known to be involved as a second messenger in the transduction of signals by several stimulatory surface receptor molecules of T cells, such as the CD3/TCR complex.24 We therefore investigated whether changes in the Gaff levels could also be involved in signalling via p58 molecules in LDGLs, displaying the typical inhibitory or the uncommon stimulatory function. No mobilization of intracellular Ca++ could be triggered by antip58 MoAb in LDGLs displaying inhibitory p58 receptor, while Ca++ mobilization could be observed only in the p58' LDGL that displayed stimulatory p58 molecule. It is therefore conceivable that the transduction of stimulatory signals via p58 complex may involve intracellular Ca++ mobilization as a second messenger, while Ca++ influx does not seem to be involved in signalling via inhibitory p58 receptor. These findings are in agreement with data from A. Moretta et a1 in CD3-NK clones displaying either stimulatory or inhibitory receptors for HLA-C molecules. 25 In conclusion, our present data indicate that functional p58 NK-related surface receptor molecules are expressed on a minority of CD3+ LDGLs. These LDGLs may represent a suitable cellular model to study the p58 NK receptor properties and its ability to modulate CD3/TCR function in a discrete, normally underepresented p58' T-cell subset.
